Further tests are needed but a trial showed that, when compared against placebo treatment, those given the drug had a 79% lower risk of developing severe disease.
Rigor acadêmico, estilo jornalístico
Todos os artigos de drug trial
Exibindo todos artigos
Preliminary results indicate dexamethasone could help treat severely ill patients in hospital with COVID-19. But it’s early days yet.
Deliberately infecting people with a disease-causing agent as part of carefully considered medical research can be ethically acceptable or even necessary.
Principais colaboradores
-
Professor and Director Academic Excellence, Macquarie University
-
Professor of Bioethics, Monash Bioethics Centre, Monash University, Monash University
-
Infectious Disease Ethics Fellow, Ethox & Wellcome Centre for Ethics and Humanities, Univeristy of Oxford. Adjunct, Monash University
-
Pharmacist and PhD Candidate, University of Sydney
